Fate Therapeutics
FATE
#7523
Rank
โ‚ฌ0.25 B
Marketcap
2,26ย โ‚ฌ
Share price
-5.10%
Change (1 day)
17.36%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -2,09ย โ‚ฌ

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,02ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,71ย โ‚ฌ a decrease over its 2021 EPS that were of -2,08ย โ‚ฌ.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,09ย โ‚ฌ-23.09%
2022-2,71ย โ‚ฌ30.49%
2021-2,08ย โ‚ฌ7.21%
2020-1,94ย โ‚ฌ45.45%
2019-1,33ย โ‚ฌ19.17%
2018-1,12ย โ‚ฌ17.65%
2017-0,95ย โ‚ฌ-3.77%
2016-0,99ย โ‚ฌ-12.4%
2015-1,13ย โ‚ฌ-3.97%
2014-1,17ย โ‚ฌ-2.09%
2013-1,20ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-7,30ย โ‚ฌ 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
5,17ย โ‚ฌ-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-8,07ย โ‚ฌ 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,89ย โ‚ฌ 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
1,83ย โ‚ฌ-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA